Concepedia

Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting

Jesse Martin, Alexis K. Williams, Melissa D. Klein, Vindhya Sriramoju, Shivanshu Madan, Joseph S. Rossi, Megan M. Clarke, Jonathan D. Cicci, Larisa H. Cavallari, Karen E. Weck,

Genetics in Medicine · 2019 · 56 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine · 2009 · 7.1K citations · Full text

, , +14

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine · 2007 · 6.7K citations · Full text

, , +1

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt et al. · Circulation · 2011 · 4.4K citations

, , +10

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Glenn N. Levine, Eric Bates, John A. Bittl et al. · Journal of the American College of Cardiology · 2016 · 1.6K citations

, , +16

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

Stuart A. Scott, Katrin Sangkuhl, Catherine M. Stein et al. · Clinical Pharmacology & Therapeutics · 2013 · 966 citations · Full text

, , +17